Your email has been successfully added to our mailing list.

×
-0.000261825798568696 -0.00157095479141217 8.72752661894825E-05 0.00279280851806592 0.00602199336707975 -0.00157095479141217 -0.00768022342468153 -0.0157095479141212
Stock impact report

UPDATE 3-Sage soars as postpartum depression drug moves closer to approval [Reuters]

Solidion Technology, Inc. (STI) 
Last solidion technology, inc. earnings: 10/17 06:00 am Check Earnings Report
Company Research Source: Reuters
Sage soars as postpartum depression drug moves closer to approval | Reuters 2 Min Read (Reuters) - Sage Therapeutics Inc’s shares surged to a record on Thursday after its postpartum depression drug succeeded in two late-stage studies, paving the way for it to bring to market the first FDA-approved treatment for the disorder. Shares were up 50 percent as the company plans to submit a marketing application for the injectable drug, brexanolone, to the U.S. Food and Drug Administration in the first half of 2018. Edward Nash, an analyst with SunTrust Robinson Humphrey, told Reuters brexanolone could be “a potential blockbuster” for the drug developer, with the intravenous version of the drug hitting peak sales of $400 million in 2026. He also said the success of a follow-on program testing an oral version could generate another $668 million. Postpartum depression, a severe form of “baby blues”, is a common complication of childbirth that affects 1 in 9 women, according to the Centers for D Show less Read more
Impact Snapshot
Event Time:
STI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for STI alerts
Opt-in for
STI alerts

from News Quantified
Opt-in for
STI alerts

from News Quantified